TN2010000321A1 - COMPOUNDS OF 3H- [1,2,3] TRIAZOLO [4,5-d] PYRIMIDINE, USES THEREOF AS INHIBITORS OF MTOR KINASE AND PI3 KINASE, AND THEIR SYNTHESIS - Google Patents

COMPOUNDS OF 3H- [1,2,3] TRIAZOLO [4,5-d] PYRIMIDINE, USES THEREOF AS INHIBITORS OF MTOR KINASE AND PI3 KINASE, AND THEIR SYNTHESIS

Info

Publication number
TN2010000321A1
TN2010000321A1 TNP2010000321A TN2010000321A TN2010000321A1 TN 2010000321 A1 TN2010000321 A1 TN 2010000321A1 TN P2010000321 A TNP2010000321 A TN P2010000321A TN 2010000321 A TN2010000321 A TN 2010000321A TN 2010000321 A1 TN2010000321 A1 TN 2010000321A1
Authority
TN
Tunisia
Prior art keywords
kinase
compounds
triazolo
pyrimidine
inhibitors
Prior art date
Application number
TNP2010000321A
Other languages
French (fr)
Inventor
Christoph Martin Dehnhardt
Aranapakam Mudumbai Venkatesan
Santos Efren Guillermo Delos
Zecheng Chen
Santos Osvaldo Dos
Natasja Brooijmans
Arie Zask
Jeroen Cunera Verheijen
Semiramis Ayral-Kaloustian
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/030939 external-priority patent/WO2009091788A1/en
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of TN2010000321A1 publication Critical patent/TN2010000321A1/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La présente invention concerne des dérivés de 3H-[1,2,3]triazolo [4,5,d] pyrimidine de formule I : ou un de leurs sels pharmaceutiquement acceptables formule dans laquelle les variables constitutives sont telles que définies dans le présent mémoire, des compositions contenant les composés, et des procédés pour la préparation et l'utilisation des composés.The present invention relates to 3H- [1,2,3] triazolo [4,5-d] pyrimidine derivatives of formula I: or a pharmaceutically acceptable salt thereof wherein the constitutive variables are as defined herein compositions containing the compounds, and methods for the preparation and use of the compounds.

TNP2010000321A 2009-01-14 2010-07-14 COMPOUNDS OF 3H- [1,2,3] TRIAZOLO [4,5-d] PYRIMIDINE, USES THEREOF AS INHIBITORS OF MTOR KINASE AND PI3 KINASE, AND THEIR SYNTHESIS TN2010000321A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/030939 WO2009091788A1 (en) 2008-01-15 2009-01-14 3h-[1,2,3]triazolo[4,5-d]pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses

Publications (1)

Publication Number Publication Date
TN2010000321A1 true TN2010000321A1 (en) 2011-12-29

Family

ID=55024448

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000321A TN2010000321A1 (en) 2009-01-14 2010-07-14 COMPOUNDS OF 3H- [1,2,3] TRIAZOLO [4,5-d] PYRIMIDINE, USES THEREOF AS INHIBITORS OF MTOR KINASE AND PI3 KINASE, AND THEIR SYNTHESIS

Country Status (1)

Country Link
TN (1) TN2010000321A1 (en)

Similar Documents

Publication Publication Date Title
TN2010000171A1 (en) THIENOPYRIMIDINE AND PYRAZOLOPYRIMIDINE DERIVATIVES AND THEIR USE AS KINASE K13 KINASE KINASE INHIBITORS
EA201001017A1 (en) 3H- [1,2,3] TRIAZOLO [4,5-D] Pyrimidine COMPOUNDS, THEIR APPLICATION AS INHIBITORS KINASE MTOR AND KINASE PI3 AND THEIR SYNTHESIS
MA31574B1 (en) PYRAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF RAF
MA31170B1 (en) 2-AMINO-5,7-DIHYDRO-6H-PYRROLO [3,4-D] PYRIMIDINE DERIVATIVES AS INHIBITORS OF HSP-90 FOR THE TREATMENT OF CANCER
MA34644B1 (en) AMINOPYRIMIDINE PYRAZOLE DERIVATIVES AS MODULATORS OF LRRK2
TN2009000085A1 (en) PYRIDO (2,3-D) PYRIMIDINONE DERIVATIVES AND THEIR USE AS PI3 INHIBITORS
MA33451B1 (en) 1,3-DISUBSTITUTED IMIDAZOLIDIN-2-ONE DERIVATIVES AS CYP INHIBITORS 17
TN2011000316A1 (en) SULFONAMIDE DERIVATIVES
MA29926B1 (en) PYRAZINE DERIVATIVES
WO2008012635A3 (en) Amine derivatives useful as anticancer agents
MA35749B1 (en) Nucleoside derivatives 4'-azido, 3'-fluoro substituted as inhibitors of vhc arn replication
MA33364B1 (en) SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS
SI1678166T1 (en) Protein kinase inhibitors
MA28270A1 (en) Pyrido [2,3-D] pyrimidine-2,4-diamines as PDE 2 inhibitors
TN2009000450A1 (en) PYRIDINE DERIVATIVES
MA30075B1 (en) PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH
RS20080533A (en) Triazolopyrazine derivatives useful as anticancer agents
TNSN07275A1 (en) SUBSTITUTED TRIAZOLE DERIVATIVES AS OCYTOCIN ANTAGONISTS
MA37405A1 (en) Heterocyclyl compounds
MA34342B1 (en) PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER
HRP20040686B1 (en) Novel heterocyclic compounds which are active as inhibitors of beta-lactamases
TNSN07022A1 (en) PYRIDINE DERIVATIVES
MA30351B1 (en) TETRAHYDROPYRIDOTHIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE
MA33384B1 (en) Heterocyclic sulfonamides, their uses and the pharmaceutical compositions they contain
MA31080B1 (en) CYCLED DERIVATIVES AS EG-5 INHIBITORS.